Search results for "early-stage cancer"

showing 2 items of 2 documents

Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Dia…

2019

Circulating tumor DNA (ctDNA) has emerged as a non-invasive &ldquo

Oncologymedicine.medical_specialtymolecular profilinglcsh:MedicineDNA sequencing03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicinemedicineMammographyLiquid biopsycirculating tumor DNA (ctDNA)GeneLymph node030304 developmental biology0303 health sciencesmedicine.diagnostic_testliquid biopsybusiness.industrylcsh:RGeneral MedicineAmpliconmedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisImmunohistochemistrybusinessearly-stage cancer
researchProduct

Detection of

2019

Circulating tumor DNA (ctDNA) has emerged as a non-invasive “liquid biopsy” for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer after mammography findings, comparing PIK3CA and TP53 mutations between tumor biopsies and pre-biopsy circulating DNA. Matched plasma and frozen fresh tissue biopsies from patients with Breast Imaging-Reporting and Data System (BIRADS) 4c/5 mammography findings and subsequent diagnosis of primary breast cancer were analyzed using NGS TruSeq Custom Amplicon Low Input Panel (Illumina) and plasma SafeSEQ (Sysmex Inostics). The same plasma and tumor mutations were observed in eight of 29 patients (27…

breast cancerliquid biopsymolecular profilingcirculating tumor DNA (ctDNA)Articleearly-stage cancerJournal of clinical medicine
researchProduct